Has Lindsey Hartsell, MD received payments from drug or device companies?

Yes. Drug and device makers reported $1,668 in general payments to Lindsey Hartsell, MD across 36 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Lindsey Hartsell, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Lindsey Hartsell, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Lindsey Hartsell, MD

Urology · Atlanta, GANPI 1891089108

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 94.5% of the total across 36 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. Boston Scientific accounts for 62.3% of it on its own, with 11 other manufacturers making up the rest. That places this record below the midpoint for urology clinicians in GA, where the typical reported total is $4,062.

$1,668in general payments, 2019–2025

Across 36 payments — averaging $46.33 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Boston Scientific$1K
Coloplast$214
Cook Medical LLC$151
Laborie Medical Technologies Corp.$70
Baxter Healthcare$57
180 Medical, Inc.$26
plus $112 from 6 others

$40,548in research payments, 2019–2025

Across 13 payments — averaging $3119.08 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

Uromedica, Incorporated$41K

What the payments were for

Food & beverage$1,57694%
Education$926%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Boston Scientific	16	$1,038
Coloplast	7	$214
Cook Medical LLC	2	$151
Laborie Medical Technologies Corp.	1	$70
Baxter Healthcare	2	$57
180 Medical, Inc.	1	$26
Johnson & Johnson	1	$25
C. R. Bard, Inc. & Subsidiaries	1	$24
Tempus AI, Inc	1	$21
Aroa Biosurgery Incorporated	2	$20
Profound Medical Corp.	1	$17
Travere Therapeutics, Inc.	1	$4

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,668 in reported general payments places this provider in the 30th percentile of 369 urology providers in Georgia.

See all urology providers in Georgia →

Medicare billing

Part B allowed, 2024

$91,970

Medicare patients

241

Services billed

588

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
GemtesaVibegron	28	$22,400
MyrbetriqMirabegron	43	$17,790
Tolterodine Tartrate	14	$1,342
Tamsulosin Hcl	80	$890
Finasteride	20	$391
Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim	83	$204
Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst	21	$184
Oxybutynin Chloride	16	$167
Cephalexin	30	$98
Tramadol Hcl	23	$50

Paid to pharmacies, not to this prescriber.

Other urology in Atlanta

Tariq HakkyAtlanta$140K
James BennettAtlanta$93K
Anthony BarnesAtlanta$89K
Matthew SandAtlanta$77K
Brendan BrowneAtlanta$53K
Rajesh LaunganiAtlanta$33K
Vikram NarayanAtlanta$29K
Gregory MitchellAtlanta$15K
Charles LorentzAtlanta$14K
Vahan KassabianRoswell$1.6M

See the full list for Georgia →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →